Tengjun Biotechnology Corp.
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.33K-1.26K-1.90K-2.36K-782.62-2.59K-6.21K-766.70-81.3731.79-1.12K-2.59K
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A199.50KN/A2.403.85N/A
Price/Book Value ratio
2.43K-1.49K-909.36-711.07-175.36-505.58-1.78K-204.80-27.7824.9546.11-175.36
Price/Cash Flow ratio
-1.42K-1.36K-2.21K-3.25K-1.18K-4.07K-12.52K-1.82K-108.46267.7488.14-1.18K
Price/Free Cash Flow ratio
-1.42K-1.36K-2.21K-3.25K-1.18K-4.07K-12.52K-271.25-69.86268.9289.09-1.18K
Price/Earnings Growth ratio
20.25-113.5063.4199.4741.74N/A-115.33-8.07-0.09-0.06-0.03N/A
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A-94094.13%N/A93.52%93.46%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A-11128.96%N/A10.69%1.09%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A-18575.17%N/A10.17%1.11%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A-26021.37%N/A7.55%-0.34%N/A
Effective Tax Rate
N/A0.92%N/A-16.48%N/AN/A-34.02%-40.08%-0.08%21.65%137.87%N/A
Return on Assets
-66.30%-4876.86%-4162.06%-1389.14%-1447.07%-1195.14%-1866.41%-736.93%-5.33%19.35%-0.88%-1447.07%
Return On Equity
-182.28%118.55%47.80%30.02%22.40%19.50%28.69%26.71%34.14%78.49%-191.59%19.50%
Return on Capital Employed
-174.89%112.79%41.51%18.22%15.09%12.19%14.12%11.42%32.29%107.29%12.62%12.62%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.98N/A
Quick Ratio
1.570.020.010.020.010.010.01-10.800.091.130.910.01
Cash ratio
1.570.020.01N/AN/AN/AN/A0.020.010.060.14N/A
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A1.11KN/A112.5885.06N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A4.24K3.53K37.5883.56N/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A5.35KN/A150.16104.54N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/A342.37302.47206.38154.37N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A5.00KN/A-56.21-48.70N/A
Debt Ratios
Debt Ratio
N/A40.4085.6544.6661.3959.5063.4589.79N/AN/A0.7759.50
Debt Equity Ratio
N/A-0.98-0.98-0.96-0.95-0.97-0.97-3.25N/AN/A3.59-0.95
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/A-55.28-60.41-27.89-19.29-33.40-39.961.44N/AN/AN/A-19.29
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A983.66N/A
Cash Flow to Debt Ratio
N/A-1.11-0.41-0.22-0.15-0.12-0.14-0.03N/AN/AN/A-0.15
Company Equity Multiplier
2.74-0.02-0.01-0.02-0.01-0.01-0.01-0.03-6.404.054.63-0.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A-109.52N/A0.000.04N/A
Free Cash Flow / Operating Cash Flow Ratio
11111116.711.550.990.981
Cash Flow Coverage Ratio
N/A-1.11-0.41-0.22-0.15-0.12-0.14-0.03N/AN/AN/A-0.15
Short Term Coverage Ratio
N/A-1.11-0.41-0.22-0.15-0.12-0.14-0.03N/AN/AN/A-0.15
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A